Literature DB >> 4793138

Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

R Peto, M C Pike.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4793138

Source DB:  PubMed          Journal:  Biometrics        ISSN： 0006-341X            Impact factor:   2.571


× No keyword cloud information.
  104 in total

1.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Authors:  Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.

Authors:  A C Queirós; N Villamor; G Clot; A Martinez-Trillos; M Kulis; A Navarro; E M M Penas; S Jayne; A Majid; J Richter; A K Bergmann; J Kolarova; C Royo; N Russiñol; G Castellano; M Pinyol; S Bea; I Salaverria; M López-Guerra; D Colomer; M Aymerich; M Rozman; J Delgado; E Giné; M González-Díaz; X S Puente; R Siebert; M J S Dyer; C López-Otín; C Rozman; E Campo; A López-Guillermo; J I Martín-Subero
Journal:  Leukemia       Date:  2014-08-25       Impact factor: 11.528

3.  Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes.

Authors:  Christina L Roland; Aihua Bian; John C Mansour; Adam C Yopp; Glen C Balch; Rohit Sharma; Xian-Jin Xie; Roderich E Schwarz
Journal:  J Surg Oncol       Date:  2011-10-17       Impact factor: 3.454

4.  Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer.

Authors:  Serap Akyurek; Cem Onal; Aysun Cagar; Ayse Hicsonmez; Meltem Nalca Andrieu; Cengiz Kurtman
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

5.  The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; J Kelly Wright; C Wright Pinson
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

6.  Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.

Authors:  Daryl Tan; Sandra J Horning; Richard T Hoppe; Ronald Levy; Saul A Rosenberg; Bronislava M Sigal; Roger A Warnke; Yasodha Natkunam; Summer S Han; Alan Yuen; Sylvia K Plevritis; Ranjana H Advani
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

7.  Radiation therapy alone versus radiation therapy and chemotherapy in the management of Hodgkin's disease.

Authors:  L D Glenn; P P Kumar
Journal:  J Natl Med Assoc       Date:  1990-02       Impact factor: 1.798

8.  Evidence for limited humoral immunoglobulin M antibody response to hepatitis B core antigen during acute and chronic hepatitis B virus infections.

Authors:  E G Lindenschmidt; C H Granato; K Kätzner; R Laufs
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

9.  Histopathologic and dietary prognostic factors for canine mammary carcinoma.

Authors:  F S Shofer; E G Sonnenschein; M H Goldschmidt; L L Laster; L T Glickman
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

10.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A DePalo
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.